Select Biosciences Market Research Reports
Browse All Reports of Select Biosciences
| Pages: « Last 1 | Displaying 1 to 19 (of 19 records) |
Title
Published Date
Price
Cellular Therapy and Cord Blood 2013 Market Report
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, ...
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, ...
February 2013
$2185
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report
This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. In this report, we focus upon technical and business trends in these spaces as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and theref...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. In this report, we focus upon technical and business trends in these spaces as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and theref...
January 2013
$2125
Companion Diagnostics and Personalized Medicine Market Report 2012
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct p...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct p...
August 2012
$1970
MicroRNAs and Exosomes Market Report 2012
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving. In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. The focus of this field is moving from basic rese...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving. In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. The focus of this field is moving from basic rese...
August 2012
$1970
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012
This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events. Also presented are ...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events. Also presented are ...
January 2012
$1620
MicroRNA Market Trends 2011
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketpla...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research that allows us to identify qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketpla...
October 2011
$1720
Circulating Tumor Cells (CTCs)Market Trends 2011
This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof. ...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastasis and mechanisms thereof. ...
July 2011
$1700
Emerging Pharmaceutical Markets 2012
The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost ...
The robust growth in the pharmaceutical markets of emerging world economies has outpaced the overall growth of the global pharmaceutical market. The emerging markets are being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases due to rapid urbanization, and low-cost ...
June 2011
$4222
Umbilical Cord Blood Banking Market Trends 2011
This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different ...
This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different ...
June 2011
$1420
Single Cell Omics 2011
The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is...
The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the variability from one cell to the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is...
May 2011
$4215
Adult Stem Cells Market Trends 2011
This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics. This report details the current s...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal stem cells; MSCs) and their properties making them highly suited for the development of cellular therapeutics. This report details the current s...
January 2011
$2005
Epigenetics Market Trends 2011
This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers. This report presents the ...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers. This report presents the ...
January 2011
$1675
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report
This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the cancer/oncology space. Cancer vacci...
This market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two areas are evolving and expanding driven by the greater emphasis on personalized medicine especially in the cancer/oncology space. Cancer vacci...
January 2011
$2675
Multiplexed Diagnostics 2010 Market Report
The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. Will the FDA finally release the updated IVDMIA guidelines? If so, will the FDA close the CLIA loophole and/or will the FDA require 510(k) approvals for all multivariate...
The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. Will the FDA finally release the updated IVDMIA guidelines? If so, will the FDA close the CLIA loophole and/or will the FDA require 510(k) approvals for all multivariate...
May 2010
$3625
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine
This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends ope...
This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends ope...
April 2010
$1618
Adult Stem Cells and iPSCs 2010 Market Report
This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with ...
This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with ...
March 2010
$2000
Single Cell Analysis 2010: the New Frontier for 'Omics Market Report
Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averag...
Omics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single cell analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averag...
January 2010
$4120
Stem Cells for Cellular Therapy 2010 Market Report
This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stem cells space is broad and comprehensive-each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on pr...
This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stem cells space is broad and comprehensive-each segment of the space is therefore analyzed and presented in detail in a market report. This market report is focused on pr...
January 2010
$2600
MicroRNA Research and Disease Associations 2010 Market Report
This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends—both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of diff...
This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends—both qualitative and quantitative trends including market size, growth rate, and projections. This report contains primary market data characterizing the microRNA research marketplace including market penetrance of diff...
January 2010
$2600
